Cytotoxic PTCL-NOS (CD8+ or CD56+ and Cytotoxic Marker)
1 clinical trials · Condition
◉ Watch Cytotoxic PTCL-NOS (CD8+ or CD56+ and Cytotoxic Marker)
| Record | Firm | Date |
|---|---|---|
| A Study of DR-01 in Subjects With Large Granular Lymphocytic Leukemia or Cytotoxic Lymphomas (NCT05475925) | Dren Bio | 2022-07-13 |
Track Cytotoxic PTCL-NOS (CD8+ or CD56+ and Cytotoxic Marker) automatically
Every clearance here is in the API, with alerts when new ones post.